OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
12.70
-0.58 (-4.37%)
At close: Jul 11, 2025, 4:00 PM
12.53
-0.17 (-1.34%)
After-hours: Jul 11, 2025, 7:57 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $234.89 million as of July 11, 2025. Its market cap has increased by 23.89% in one year.
Market Cap
234.89M
Enterprise Value
251.11M
1-Year Change
23.89%
Ranking
Category
Stock Price
$12.70
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $234.89M, an increase of 586.81%. That is a compound annual growth rate of 31.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 245.60M | 174.41% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |